title: [Effect of colloid bismuth treatment on Campylobacter pylori infection of the gastric mucosa and the clinical course of non-ulcer dyspepsia].
abstract: There are suggestions, that the idiopathic non-ulcer dyspepsia is related to the chronic gastritis type B coexisting with C. pylori infection. Presented studies were aimed at the assessing of an effect of the treatment with De-Nol on the course of the idiopathic non-ulcer dyspepsia of C. pylori infection. Gastroscopic examination was performed in 52 patients with non-ulcer dyspepsia before and after the treatment with De-Nol administered for 4-8 weeks. Campylobacter pylori was isolated from 71% of patients with idiopathic non-ulcer dyspepsia. An infection was eradicated in 97.4% of patients treated with De-Nol. The number of dyspeptic episodes decreased in by 96% of patients, including 33% of patients in whom total recovery was noted. De-Nol was well tolerated. De-Nol is highly effective in the eradication of C. pylori and produces clinical improvement in the majority of patients with non-ulcer dyspepsia.
authors.affiliation: Kliniki Gastroenterologii i Chorób Przemiany Materii, Warszawie.
authors.forename: J
authors.initials: J
authors.lastname: Muszyński
authors.forename: D
authors.initials: D
authors.lastname: Biernacka
authors.forename: E
authors.initials: E
authors.lastname: Bogacka-Zatorska
authors.forename: M
authors.initials: M
authors.lastname: Stepka
authors.forename: A
authors.initials: A
authors.lastname: Galczak
authors.forename: L
authors.initials: L
authors.lastname: Zalewski
authors.forename: K
authors.initials: K
authors.lastname: Lissowska
authors.forename: A
authors.initials: A
authors.lastname: Ehrmann
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000863:Antacids / Q000627:therapeutic use*; D002908:Chronic Disease; D004415:Dyspepsia / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects; D005756:Gastritis / Q000150:complications / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000627:therapeutic use*
chemical_list: D000863:Antacids; D009942:Organometallic Compounds; C002791:bismuth tripotassium dicitrate
vernacular_title: Wpływ leczenia bizmutem koloidalnym na zakaåenie błony śluzowej zoładka przez Campylobacter pylori i przebieg kliniczny idiopatycznej dyspepsji niewrzodowej.